<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Lowry Laursen | Activity</title>
	<link>http://toxicdolls.com/members/weightsoccer54/activity/</link>
	<atom:link href="http://toxicdolls.com/members/weightsoccer54/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lowry Laursen.</description>
	<lastBuildDate>Mon, 09 Nov 2026 14:07:31 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">f8e0623a27ca6c6b0f0f3bf85895f67b</guid>
				<title>Lowry Laursen posted an update: Background and purpose - Involvement of patient organizations [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/60326/</link>
				<pubDate>Fri, 18 Jul 2025 12:20:18 +0000</pubDate>

									<content:encoded><![CDATA[<p>Background and purpose &#8211; Involvement of patient organizations is steadily increasing in guidelines for treatment of various diseases and conditions for better care from the patient&#8217;s viewpoint and better comparability of outcomes. For this reason, the Osteogenesis Imperfecta Federation Europe and the Care4BrittleBones Foundation convened an&hellip;<span class="activity-read-more" id="activity-read-more-60326"><a href="http://toxicdolls.com/activity-2/p/60326/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b4b7952a6de5df155582de49c060319e</guid>
				<title>Lowry Laursen posted an update: We aim to assess the long-term oncological outcomes of [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/55801/</link>
				<pubDate>Tue, 15 Jul 2025 12:49:46 +0000</pubDate>

									<content:encoded><![CDATA[<p>We aim to assess the long-term oncological outcomes of children with bladder/prostate rhabdomyosarcoma (B/P RMS) treated with multiagent chemotherapy as a monotherapy. We hypothesize that a highly select patient subset can be treated with multiagent chemotherapy as a monotherapy and spared the morbidity of local treatment with similar oncological&hellip;<span class="activity-read-more" id="activity-read-more-55801"><a href="http://toxicdolls.com/activity-2/p/55801/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">52bf962f4db95e69344eecede7bcbcf2</guid>
				<title>Lowry Laursen posted an update: During early HIV-1 infection, immunodominant T cell responses [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/41222/</link>
				<pubDate>Thu, 10 Jul 2025 15:06:55 +0000</pubDate>

									<content:encoded><![CDATA[<p>During early HIV-1 infection, immunodominant T cell responses to highly variable epitopes lead to the establishment of immune escape virus variants. Here we assessed a type 1-polarized monocyte-derived dendritic cell (MDC1)-based approach to selectively elicit cytotoxic T lymphocyte (CTL) responses against highly conserved and topologically&hellip;<span class="activity-read-more" id="activity-read-more-41222"><a href="http://toxicdolls.com/activity-2/p/41222/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">29591bdf06a3dde68198a2b475f57cae</guid>
				<title>Lowry Laursen became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/41150/</link>
				<pubDate>Thu, 10 Jul 2025 14:27:16 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>